Evidence map›Paper›PMID 32647813›Full record

ArticleJournal of structural biology: X

Parsing the functional specificity of Siderocalin/Lipocalin 2/NGAL for siderophores and related small-molecule ligands.

Matthew C Clifton, Peter B Rupert, Trisha M Hoette, Kenneth N Raymond, Rebecca J Abergel, Roland K Strong

Open access · goldAbstract read
In one paragraph

Article in Journal of structural biology: X. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Role of Small Molecule Ligands in IgE-Mediated Allergy.Current allergy and asthma reports · 2023
    Review
  8. Article
  9. Article
  10. The Purified Siderophore fromMolecules (Basel, Switzerland) · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Bacterial Endophyte Community Dynamics in Apple (Journal of fungi (Basel, Switzerland) · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Matthew C CliftonDivision of Basic Science, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Peter B RupertDivision of Basic Science, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Trisha M HoetteDepartment of Chemistry, University of California, Berkeley, CA 94720-1460, USA.
Kenneth N RaymondDepartment of Chemistry, University of California, Berkeley, CA 94720-1460, USA.
Rebecca J AbergelDepartment of Chemistry, University of California, Berkeley, CA 94720-1460, USA.
Roland K StrongDivision of Basic Science, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Fred Hutch Cancer Center · USUniversity of California, Berkeley · US

Funding

IRON LIPOCALIN NGAL IN KIDNEY DISEASER01DK073462 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BARASCH, JONATHAN M. · 2007 to 2015
$3.0M
Microbial siderophore-specific innate immune responsesR01AI059432 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STRONG, ROLAND K · 2005 to 2008
$1.1M
Analysis of NGAL Metabolism Identifies a Therapy for Iron OverloadR21DK091729 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BARASCH, JONATHAN M. · 2011 to 2012
$437k
NIAID NIH HHS HHSN272201700059CNIAID NIH HHS R01 AI059432NIDDK NIH HHS R01 DK073462NIDDK NIH HHS R21 DK091729
6 · The paper itself

Abstract

Siderocalin/Lipocalin 2/Neutrophil Gelatinase Associated Lipocalin/24p3 is an innate immune system protein with bacteriostatic activity, acting by tightly binding and sequestering diverse catecholate and mixed-type ferric siderophores from enteric bacteria and mycobacteria. Bacterial virulence achieved through siderophore modifications, or utilization of alternate siderophores, can be explained by evasion of Siderocalin binding. Siderocalin has also been implicated in a wide variety of disease processes, though often in seemingly contradictory ways, and has been proposed to bind to a broader array of ligands beyond siderophores. Using structural, directed mutational, and binding studies, we have sought to rigorously test, and fully elucidate, the Siderocalin recognition mechanism. Several proposed ligands fail to meet rigorous binding criteria, including the bacterial siderophore pyochelin, the iron-chelating catecholamine hormone norepinephrine, and the bacterial second messenger cyclic diguanylate monophosphate. While possessing a remarkably rigid structure, in principle simplifying analyses of ligand recognition, understanding Scn recognition is complicated by the observed conformational and stoichiometric plasticity, and instability, of its

Indexed as

ABC, ATP‐binding cassetteAEB, aerobactinAntimicrobial responsesAU, crystallographic asymmetric unitBacterial substrate binding proteinsBOCT, brain-type organic cation receptorCAM, catecholc-di-GMP, cyclic diguanylate monophosphateCMB, carboxymycobactinDHBA, dihydroxybenzoic acidENT, enterobactin or enterochelinFerric enterobactin/enterochelinFQ, fluorescence quenchingHOPO, hydroxypyridinoneNE, norepinephrineNGAL, Neutrophil Gelatinase Associated LipocalinPBP, bacterial periplasmic binding proteinPCH, pyochelinPDB, Research Collaboratory for Structural Biology Protein DatabankPVD, pyoverdineSBP, bacterial membrane-associated, substrate-binding proteinSCH, schizokinenScn, SiderocalinX-ray crystallography

Identifiers

PMID32647813
PMCPMC7337064
OpenAlexW2947022890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.